New members added to the clinical evidence-based study of Mengyang brand polyporus polysaccharide capsules -2022 edition "Interpretation of Clinical Pathway Therapy Drugs"

2023-10-19

The exclusive medical insurance product of Hubei Mengyang Pharmaceutical Co., Ltd. - Polyporus umbellatus polysaccharide capsule was successfully included in the 2022 version of Clinical Pathway Treatment Drug Interpretation infectious diseases Volume through the evaluation of more than 100 experts nationwide due to its exact clinical efficacy and sufficient evidence-based evidence.

"Zhuling Polysaccharide Capsules" is a new drug successfully developed by the Chinese Academy of Traditional Chinese Medicine. Zhuling Polysaccharide has been extensively studied in China for a long time, and its liver protection and enhancement of immune function have achieved good therapeutic effects in the clinical treatment of chronic hepatitis B and tumors.

✔ Guidelines for Traditional Chinese Medicine Diagnosis and Treatment of Chronic Hepatitis B



✔ Consensus of Traditional Chinese Medicine Diagnosis and Treatment Experts on Chronic Hepatitis B



✔ Interpretation of Clinical Pathway Therapy Drugs infectious diseases



✔ The most competitive new varieties of digestive drugs in the market


The clinical pathway is a standardized and standardized diagnostic and treatment standard developed by hospital management personnel, physicians, caregivers, pharmacists, medical technicians, and other multidisciplinary experts, integrating various diagnostic and treatment measures such as examination, testing, diagnosis, treatment, and nursing for specific diseases or combinations of cases. Carrying out clinical pathway work is an important way to achieve healthcare optimization, systematization, standardization, and full process quality management.

In order to better guide medical institutions in carrying out clinical pathway management and ensure the smooth progress of clinical pathway management pilot work, the Chinese Academy of Medical Sciences is commissioned by the Ministry of Health to organize the compilation of the "Interpretation of Clinical Pathways". The definition of clinical pathway is a clarification and supplementary explanation of clinical pathway, aimed at helping medical staff and management personnel in trial clinical pathway medical units accurately understand, grasp, and correctly use clinical pathways, interpret each specific operational process, standardize medical behavior, improve medical quality, and ensure medical safety.





Hot news

Service hotline

0724-8886111

Address:3 Fuyao Yi Lu, Doudao District, Jingmen City, Hubei Province, China
Transmissionh:0724-8686500
Email:hbmy_monyan@163.com

COPYRIGHT© 2022 Hubei Mengyang Pharmaceutical Co., LTD. All Rights Reserved E ICP 11014915; Internet Drug Information Service Certificate No. : (E) - Non-business -2016-0032

Technical Support: SUMA